1283378-96-0

Upstream product

• 67-56-1 methanol 
• 32701-82-9 (1-benzyl-3,5-dimethyl-1H-pyrazol-4-yl)acetic acid 

Downstream Products

• 1322081-38-8 [1-(4-aminobenzyl)-3,5-dimethyl-1H-pyrazol-4-yl]acetic acid methyl ester 
• 1322082-81-4 [1-(4-benzyloxycarbonylamino-benzyl)-3,5-dimethyl-1H-pyrazol-4-yl]-acetic acid 
• 1322083-00-0 {1-[4-(3-benzyl-ureido)-benzyl]-3,5-dimethyl-1H-pyrazol-4-yl}-acetic acid 
• 1322083-01-1 [1-(4-benzenesulfonylamino-benzyl)-3,5-dimethyl-1H-pyrazol-4-yl]-acetic acid 
• 1322083-08-8 {1-[4-(4-chloro-benzylamino)-benzyl]-3,5-dimethyl-1H-pyrazol-4-yl}-acetic acid 
• 1322084-19-4 N-{4-[(3,5-dimethyl-4-{[(2-methylpropane-2-sulfonyl)carbamoyl]methyl}-1H-pyrazol-1-yl)methyl]phenyl}-4-(trifluoromethyl)benzamide 
• 1322081-31-1 {3,5-dimethyl-1-[4-(4-trifluoromethyl-benzoylamino)-benzyl]-1H-pyrazol-4-yl}-acetic acid 
• 1322081-35-5 [3,5-dimethyl-1-(4-nitro-benzyl)-1H-pyrazol-4-yl]-acetic acid methyl ester 

Relevant academic research and scientific papers

PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS

The present invention relates to pyrazole compounds of formula (I) and pharmaceutically acceptable salts thereof having CRTH2-activity, wherein W, L1, L2, X, L3, Y, R1 and R2 are as defined in the spe

PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS

The present invention relates to pyrazole compounds of formula (I) and pharmaceutically acceptable salts thereof having CRTH2-activity, wherein W, L1, L2, X, L3, Y, R1 and R2 are as defined in the spe